These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30382303)

  • 21. Brain metabolic signatures across the Alzheimer's disease spectrum.
    Sala A; Caprioglio C; Santangelo R; Vanoli EG; Iannaccone S; Magnani G; Perani D
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):256-269. PubMed ID: 31811345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration.
    Levin F; Ferreira D; Lange C; Dyrba M; Westman E; Buchert R; Teipel SJ; Grothe MJ;
    Alzheimers Res Ther; 2021 Feb; 13(1):49. PubMed ID: 33608059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's disease.
    Massa F; Chincarini A; Bauckneht M; Raffa S; Peira E; Arnaldi D; Pardini M; Pagani M; Orso B; Donegani MI; Brugnolo A; Biassoni E; Mattioli P; Girtler N; Guerra UP; Morbelli S; Nobili F
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1263-1274. PubMed ID: 34651219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L; Wu X; Li R; Chen K; Long Z; Zhang J; Guo X; Yao L;
    J Alzheimers Dis; 2016; 51(4):1045-56. PubMed ID: 26923024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessing the reliability to detect cerebral hypometabolism in probable Alzheimer's disease and amnestic mild cognitive impairment.
    Wu X; Chen K; Yao L; Ayutyanont N; Langbaum JB; Fleisher A; Reschke C; Lee W; Liu X; Alexander GE; Bandy D; Foster NL; Thompson PM; Harvey DJ; Weiner MW; Koeppe RA; Jagust WJ; Reiman EM;
    J Neurosci Methods; 2010 Oct; 192(2):277-85. PubMed ID: 20678521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of
    Presotto L; Ballarini T; Caminiti SP; Bettinardi V; Gianolli L; Perani D
    Neuroinformatics; 2017 Apr; 15(2):151-163. PubMed ID: 28063108
    [No Abstract]   [Full Text] [Related]  

  • 27. Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares.
    Wang P; Chen K; Yao L; Hu B; Wu X; Zhang J; Ye Q; Guo X;
    J Alzheimers Dis; 2016 Aug; 54(1):359-71. PubMed ID: 27567818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alzheimer's Disease Diagnosis Based on Cortical and Subcortical Features.
    Gupta Y; Lee KH; Choi KY; Lee JJ; Kim BC; Kwon GR
    J Healthc Eng; 2019; 2019():2492719. PubMed ID: 30944718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment.
    Garibotto V; Trombella S; Antelmi L; Bosco P; Redolfi A; Tabouret-Viaud C; Rager O; Gold G; Giannakopoulos P; Morbelli S; Nobili F; Perneczky R; Didic M; Guedj E; Drzezga A; Ossenkoppele R; Berckel BV; Ratib O; Frisoni GB
    Curr Alzheimer Res; 2020; 17(13):1186-1194. PubMed ID: 33583380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia.
    Chiotis K; Saint-Aubert L; Rodriguez-Vieitez E; Leuzy A; Almkvist O; Savitcheva I; Jonasson M; Lubberink M; Wall A; Antoni G; Nordberg A
    Mol Psychiatry; 2018 Jul; 23(7):1666-1673. PubMed ID: 28507319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducible evaluation of classification methods in Alzheimer's disease: Framework and application to MRI and PET data.
    Samper-González J; Burgos N; Bottani S; Fontanella S; Lu P; Marcoux A; Routier A; Guillon J; Bacci M; Wen J; Bertrand A; Bertin H; Habert MO; Durrleman S; Evgeniou T; Colliot O; ;
    Neuroimage; 2018 Dec; 183():504-521. PubMed ID: 30130647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.
    Mosconi L
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):486-510. PubMed ID: 15747152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Meta-analysis based SVM classification enables accurate detection of Alzheimer's disease across different clinical centers using FDG-PET and MRI.
    Dukart J; Mueller K; Barthel H; Villringer A; Sabri O; Schroeter ML;
    Psychiatry Res; 2013 Jun; 212(3):230-6. PubMed ID: 23149027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential Clinical Value of Multiparametric PET in the Prediction of Alzheimer's Disease Progression.
    Chen X; Zhou Y; Wang R; Cao H; Reid S; Gao R; Han D;
    PLoS One; 2016; 11(5):e0154406. PubMed ID: 27183116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.
    Zhan Y; Chen K; Wu X; Zhang D; Zhang J; Yao L; Guo X;
    J Alzheimers Dis; 2015; 47(4):1057-67. PubMed ID: 26401783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Support vector machine-based classification of neuroimages in Alzheimer's disease: direct comparison of FDG-PET, rCBF-SPECT and MRI data acquired from the same individuals.
    Ferreira LK; Rondina JM; Kubo R; Ono CR; Leite CC; Smid J; Bottino C; Nitrini R; Busatto GF; Duran FL; Buchpiguel CA
    Braz J Psychiatry; 2018; 40(2):181-191. PubMed ID: 28977066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E; Castellano CA; Fortier M; Bocti C; Fulop T; Paquet N; Cunnane SC
    Exp Gerontol; 2018 Jul; 107():18-26. PubMed ID: 28709938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
    Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
    Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter validation of [
    D'hulst L; Van Weehaeghe D; Chiò A; Calvo A; Moglia C; Canosa A; Cistaro A; Willekens SM; De Vocht J; Van Damme P; Pagani M; Van Laere K
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):570-577. PubMed ID: 29862846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Alzheimer Disease From Mild Cognitive Impairment With a Deep Belief Network Based on 18F-FDG-PET Images.
    Shen T; Jiang J; Lu J; Wang M; Zuo C; Yu Z; Yan Z
    Mol Imaging; 2019; 18():1536012119877285. PubMed ID: 31552787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.